| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Jul―03 |
Emerging risks and (liability) insurance in the time of pandemics |
Ina Ebert, Michael Faure, Ernst Karner |
| 2 |
[GO] |
2023―May―30 |
Providing pandemic business interruption coverage with double trigger cat bonds |
André Schmitt, Sandrine Spaeter |
| 3 |
[GO] |
2023―May―19 |
COVID-19 off-label uses of medicines: the role of civil liability and regulation |
Andrea Parziale |
| 4 |
[GO] |
2023―Apr―08 |
English tort law and the pandemic: the dog that has not barked |
David Howarth |
| 5 |
[GO] |
2023―Mar―27 |
Business interruption insurance as a means of spreading pandemic-related losses |
Piotr Tereszkiewicz |
| 6 |
[GO] |
2023―Mar―26 |
The possibilities and limits of insurance as governance in insuring pandemics |
Qihao He, Michael Faure, Chengwei Liu |
| 7 |
[GO] |
2023―Feb―17 |
Reinsuring pandemics: the role of government and public-private partnerships between reinsurers and governments |
Senara Eggleton, Özlem Gürses |
| 8 |
[GO] |
2023―Jan―28 |
Capital issuances and premium growth in the property-liability insurance industry: evidence from the financial crisis and COVID-19 recession |
Thomas R. Berry-Stölzle, Meghan Irene Esson |
| 9 |
[GO] |
2021―Oct―04 |
Suspension of insurers’ dividends as a response to the COVID-19 crisis: evidence from the European insurance equity market |
Petr Jakubik, Saida Teleu |
| 10 |
[GO] |
2021―Mar―18 |
Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic |
Patrick M. Liedtke |
